Rashidi Sajad, Sánchez-Montejo Javier, Mansouri Reza, Ali-Hassanzadeh Mohammad, Savardashtaki Amir, Bahreini Mohammad Saleh, Karimazar Mohammadreza, Manzano-Román Raúl, Nguewa Paul
Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran.
Infectious and Tropical Diseases Group (e-INTRO), Institute of Biomedical Research of Salamanca-Research Center for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
Animals (Basel). 2022 Apr 23;12(9):1098. doi: 10.3390/ani12091098.
is a pathogenic protozoan parasite that infects the nucleated cells of warm-blooded hosts leading to an infectious zoonotic disease known as toxoplasmosis. The infection outcomes might be severe and fatal in patients with immunodeficiency, diabetes, and pregnant women and infants. The One Health approach to toxoplasmosis highlights that the health of humans is closely related to the health of animals and our common environment. The presence of drug resistance and side effects, the further improvement of sensitivity and specificity of serodiagnostic tools and the potentiality of vaccine candidates to induce the host immune response are considered as justifiable reasons for the identification of novel targets for the better management of toxoplasmosis. Thus, the identification of new critical proteins in the proteome of parasites can also be helpful in designing and test more effective drugs, vaccines, and diagnostic tools. Accordingly, in this study we present important proteins found in the proteome of the life cycle-specific stages of parasites that are potential diagnostic or vaccine candidates. The current study might help to understand the complexity of these parasites and provide a possible source of strategies and biomolecules that can be further evaluated in the pathobiology of parasites and for diagnostics and vaccine trials against this disease.
是一种致病性原生动物寄生虫,可感染温血宿主的有核细胞,导致一种名为弓形虫病的传染性人畜共患病。对于免疫缺陷患者、糖尿病患者以及孕妇和婴儿,感染后果可能严重甚至致命。弓形虫病的“同一健康”方法强调,人类健康与动物健康以及我们共同的环境密切相关。耐药性和副作用的存在、血清诊断工具敏感性和特异性的进一步提高以及候选疫苗诱导宿主免疫反应的潜力,被视为确定新靶点以更好地管理弓形虫病的合理理由。因此,鉴定寄生虫蛋白质组中的新关键蛋白也有助于设计和测试更有效的药物、疫苗和诊断工具。据此,在本研究中,我们展示了在寄生虫生命周期特定阶段的蛋白质组中发现的重要蛋白质,这些蛋白质是潜在的诊断或疫苗候选物。当前的研究可能有助于理解这些寄生虫的复杂性,并提供策略和生物分子的可能来源,可在寄生虫的病理生物学以及针对该疾病的诊断和疫苗试验中进一步评估。
Animals (Basel). 2022-4-23
Front Cell Infect Microbiol. 2020
Microb Pathog. 2021-6
Clin Exp Vaccine Res. 2018-7
Ir J Med Sci. 2023-2
Front Cell Infect Microbiol. 2021